<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Guides</title>
	<atom:link href="http://i-base.info/guides/feed" rel="self" type="application/rss+xml" />
	<link>http://i-base.info/guides</link>
	<description>HIV treatment guides</description>
	<lastBuildDate>Fri, 11 May 2012 15:06:29 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Treatment passport</title>
		<link>http://i-base.info/guides/2513</link>
		<comments>http://i-base.info/guides/2513#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:08:37 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2513</guid>
		<description><![CDATA[Record your treatment

Side effects diary and other charts from our Treatment Passport to record your CD4 count, viral load, treatment history and other information. September 2009
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2513/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical trials: a community guide to HIV research</title>
		<link>http://i-base.info/guides/6373</link>
		<comments>http://i-base.info/guides/6373#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:07:07 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=6373</guid>
		<description><![CDATA[Community guide to HIV research
how clinical trials work, why they are important, understanding the results and the role of the advocate in research. March 2009.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/6373/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hepatitis C for people living with HIV</title>
		<link>http://i-base.info/guides/2481</link>
		<comments>http://i-base.info/guides/2481#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:06:10 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2481</guid>
		<description><![CDATA[Hepatitis C for people living with HIV
What is hepatitis C? Testing and diagnosis. Monitoring tests. Liver biopsy and Fibroscan. Treatment options. Living with hepatitis C coinfection. March 2009.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Side effects and other complications</title>
		<link>http://i-base.info/guides/2497</link>
		<comments>http://i-base.info/guides/2497#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:05:46 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2497</guid>
		<description><![CDATA[Side effects and other complications

How side effects occur. Recording side effects. Communicating with you doctor. Individual short and long term side affects. Tips to help. December 2010.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2497/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Changing treatment</title>
		<link>http://i-base.info/guides/2506</link>
		<comments>http://i-base.info/guides/2506#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:03:27 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2506</guid>
		<description><![CDATA[Changing treatment
Second-line therapy and drug resistance. Why treatment stops working and when to change. February 2011.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2506/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV, pregnancy and women&#039;s health</title>
		<link>http://i-base.info/guides/2501</link>
		<comments>http://i-base.info/guides/2501#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:02:28 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2501</guid>
		<description><![CDATA[HIV, pregnancy and women&#8217;s health
Planning your pregnancy. HIV treatment when pregnant. Important monitoring tests. Stopping your baby getting HIV. After baby is born. September 2011.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2501/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV testing and risks of sexual transmission</title>
		<link>http://i-base.info/guides/6356</link>
		<comments>http://i-base.info/guides/6356#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:01:31 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=6356</guid>
		<description><![CDATA[HIV testing and sexual transmission
Sexual health for you and your partner. Understanding transmission risks. How and when to test. What the results mean.  January 2012.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/6356/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Introduction to combination therapy</title>
		<link>http://i-base.info/guides/2473</link>
		<comments>http://i-base.info/guides/2473#comments</comments>
		<pubDate>Sun, 01 Apr 2012 12:00:15 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2473</guid>
		<description><![CDATA[
Introduction to combination therapy
What is combination therapy?  How does it work? CD4 and viral load tests. When to start. Which drug. Side effects, adherence and resistance. April 2012.
]]></description>
		<wfw:commentRss>http://i-base.info/guides/2473/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Eviplera (rilpivirine + tenofovir + FTC)</title>
		<link>http://i-base.info/guides/5912</link>
		<comments>http://i-base.info/guides/5912#comments</comments>
		<pubDate>Thu, 08 Dec 2011 16:35:50 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[NNRTIs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=5912</guid>
		<description><![CDATA[

EV-ee-PLEER-a

Eviplea is the European tradename for a fixed dose combination of rilpivirine, tenofovir and FTC.
In the US Eviplera is called Complera.
Standard adult dose: 1 pill once-daily (not approved for people younger than 18 years old).
Take with food &#8211; at least 5oo kcal. Absorption of rilpivirine is reduced by 40% if taken without food.
Side effects: as with individual drugs. These include depressive [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/5912/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>rilpivirine</title>
		<link>http://i-base.info/guides/5904</link>
		<comments>http://i-base.info/guides/5904#comments</comments>
		<pubDate>Wed, 30 Nov 2011 18:56:45 +0000</pubDate>
		<dc:creator>Simon Collins</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://i-base.info/guides/?p=5904</guid>
		<description><![CDATA[

ril-PIV-ir-reen

Rilpivirine  (tradename Edurant, developed as TMC-278) is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Standard adult dose: 1 x 25 mg tablet, once daily &#8211; at the same time each day.
Take with food &#8211; at least 5oo kcal. Absorption is reduced by 40% if taken without food.
Side effects: depressive disorders (depressed mood, depression, mood altered, negative thoughts, [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/5904/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Atripla (efavirenz + tenofovir + FTC)</title>
		<link>http://i-base.info/guides/1561</link>
		<comments>http://i-base.info/guides/1561#comments</comments>
		<pubDate>Mon, 01 Aug 2011 12:00:08 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[NNRTIs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=1561</guid>
		<description><![CDATA[
 a-TRIP-lar

Atripla is the European tradename for a fixed dose combination of efavirenz, tenofovir and FTC.
In resource-limited countries this is a white tablet with the same design.
Standard adult dose: 1 pill once-daily
Take on an empty stomach (or not with a high fat meal).
Side effects: sleep disturbance (including nightmares), mood changes (including anxiety and depression), rash, liver toxicity, lipid changes, kidney [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/1561/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>T-20</title>
		<link>http://i-base.info/guides/3571</link>
		<comments>http://i-base.info/guides/3571#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:05:45 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Entry inhibitors]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3571</guid>
		<description><![CDATA[
TEE-twen-tee (en-FUE-veer-tide)

T-20 (enfuvirtide, tradename Fuzeon) is an entry inhibitor and fusion inhibitor.
Standard dose: 1 x 90 mg sub-cutaneous (under the skin) injection, twice-daily.
Take with or without food.
Side effects: injection site reactions, bacterial pneumonia, allergy.
Other comments: T-20 is only used in people who have extensive drug resistance. Because of the inconvenience of a twice-daily injection, T-20 [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3571/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>etravirine</title>
		<link>http://i-base.info/guides/3569</link>
		<comments>http://i-base.info/guides/3569#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:05:27 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3569</guid>
		<description><![CDATA[
eht-RAHV-a-reen

Etravirine  (tradename Intelence, developed as TMC-125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Standard adult dose: 2 x 100 mg tablets, twice daily. Note that higher and lower doses are used in some combinations.
Take with food.
Side effects: rash, nausea, liver problems.
Other notes: etravirine is active in many people who developed resistance to either nevirapine or efavirenz. For [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3569/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>raltegravir</title>
		<link>http://i-base.info/guides/3567</link>
		<comments>http://i-base.info/guides/3567#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:05:03 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Integrase inhibitors]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3567</guid>
		<description><![CDATA[
 ral-TEG-rav-veer

Raltegravir (tradename Isentress) is an integrase inhibitor.
Standard dose: 1 x 400mg tablet, twice daily.
Can be taken with or without food.
Side effects: diarrhea, nausea, and headache. May rarely cause depression. This is a relatively new drug with more limited information on side effects.
Other notes: raltegravir can be used in combination with other sensitive drugs to [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3567/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>maraviroc</title>
		<link>http://i-base.info/guides/3565</link>
		<comments>http://i-base.info/guides/3565#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:04:00 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Entry inhibitors]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3565</guid>
		<description><![CDATA[
 ma-RAV-veer-OCK

Maraviroc (tradenames Celsentri in Europe and Selzentry in the US) is a CCR5 inhibitor.
Standard doses: 1 x 150, 300 or 600 mg tablet, twice daily, depending on the other drugs in the combination. Available as 150 mg and 300 mg tablets.
Take with or without food.
Side effects: rash, muscle and joint pain, stomach pain, dizziness. [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3565/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>nelfinavir</title>
		<link>http://i-base.info/guides/3563</link>
		<comments>http://i-base.info/guides/3563#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:02:44 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3563</guid>
		<description><![CDATA[
 nell-FIN-a-veer

Nelfinavir (tradename Viracept in Europe) is a protease inhibitor.
Standard adult dose: 5 x 250 mg tablets twice daily.
Take with food.
Side effects: diarrhoea, lipid changes including lipodystrophy.
Other notes: nelfinavir is an older drug that is rarely used in the UK because it is less effective and has more difficult side effects than newer alternatives. Nelfinavir [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3563/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>tipranavir</title>
		<link>http://i-base.info/guides/3561</link>
		<comments>http://i-base.info/guides/3561#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:02:09 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3561</guid>
		<description><![CDATA[
 tip-RAN-a-veer

Tipranavir (tradename Aptivus) is a protease inhibitor that needs to be boosted with a separate dose of ritonavir.
Standard adult dose: 2 x 250 mg capsules, plus 2 x 100 mg ritonavir, both twice-daily.
Take with food.
Side effects: changes in lipids (blood fat) which should be routinely monitored, lipodystrophy (fat accumulation), diarrhoea, tiredness, nausea. May increase the risk [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3561/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trizivir (AZT + 3TC + abacavir)</title>
		<link>http://i-base.info/guides/3559</link>
		<comments>http://i-base.info/guides/3559#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:01:25 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3559</guid>
		<description><![CDATA[
TRIZ-iv-veer

Trizivir is the tradename for a fixed dose combination of 3TC, abacavir and AZT.
Standard adult dose: one tablet, twice-daily.
Take with or without food.
Side effects: nausea, vomiting, fatigue, anaemia (low red blood cells), fat loss, muscle pain and weakness. Darkening of skin and nails in some people. Rarely, hair loss. Hypersensitivity reaction from abacavir. A genetic test, [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3559/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ritonavir</title>
		<link>http://i-base.info/guides/3557</link>
		<comments>http://i-base.info/guides/3557#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:01:08 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3557</guid>
		<description><![CDATA[ .     
New metrex tablet        Old (original) capsule
(non-refrigerated)        (requires refrigeration)
 rit-on-a-veer

Ritonavir (tradename Norvir) is a protease inhibitor that is now only used as a booster for other PIs. Ritonavir boosting allows you to use a lower dose of the boosted PI, and makes the PI last longer in your body.
Lopinavir/r (Kaletra) includes [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3557/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>darunavir</title>
		<link>http://i-base.info/guides/3555</link>
		<comments>http://i-base.info/guides/3555#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:00:54 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3555</guid>
		<description><![CDATA[
 da-ROO-na-veer

Darunavir (tradename Prezista in Europe, developed as TMC-114) is a protease inhibitor that needs to be taken with a separate boosting dose of ritonavir.
Standard adult doses: different doses are currently recommended. If darunavir is being used in your first combination: 2 x 400 mg tablets plus 100 mg ritonavir, all once-daily. For people who have used HIV treatment before: [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3555/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>saquinavir</title>
		<link>http://i-base.info/guides/3553</link>
		<comments>http://i-base.info/guides/3553#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:00:38 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3553</guid>
		<description><![CDATA[
 sa-KWIN-a-veer

Saquinavir (tradename Invirase) is a protease inhibitor that needs to be boosted with a separate dose of ritonavir
Standard adult dose: 2 x 500 mg capsules, twice-daily plus a separate dose of 1 x 100 mg capsule of ritonavir.
Take with food.
Side effects: changes in lipids (blood fat) which should be routinely monitored, lipodystrophy (fat accumulation) and diarrhoea.
Other [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3553/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>fosamprenavir</title>
		<link>http://i-base.info/guides/3551</link>
		<comments>http://i-base.info/guides/3551#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:00:23 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3551</guid>
		<description><![CDATA[
 FOS-am-PREN-a-veer

Fosamprenavir (tradenames Telzir in Europe and Levixa in the US) is a protease inhibitor.
Standard adult dose: 1 x 700mg table, twice-daily. Each dose taken with a separate dose of ritonavir. Other doses are possible in some patients.
Taken with food.
Side effects: changes in lipids (blood fat) which should be routinely monitored, lipodystrophy (fat accumulation) and diarrhoea.
Other [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3551/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>indinavir</title>
		<link>http://i-base.info/guides/3549</link>
		<comments>http://i-base.info/guides/3549#comments</comments>
		<pubDate>Tue, 12 Jan 2010 10:00:03 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3549</guid>
		<description><![CDATA[
 in-DIN-a-veer

Indinavir (tradename Crixivan in Europe) is a protease inhibitor that was generally used with a boosting dose of ritonavir. Indinavir is now rarely used in any country.
Standard adult dose: 2 x 400 mg capsules, twice daily. Each dose taken with a separate 100 mg dose of ritonavir. Other doses have been studied.
Side effects: crystals in the [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3549/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kaletra (lopinavir/r)</title>
		<link>http://i-base.info/guides/3547</link>
		<comments>http://i-base.info/guides/3547#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:59:45 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3547</guid>
		<description><![CDATA[
KAL-ee-tra (lo-PIN-a-veer)

Kaletra is a combination of a protease inhibitor lopinavir (200 mg) plus a booster dose (50 mg) of ritonavir in the same pill. (tradename Kaletra in Western countries and Aluvia in low income countries).
In resource-limited countries this is a brown tablet with the same design (tradename Aluvia).
Standard adult dose: 2 x 250 mg tablets, twice-daily.
Alternative [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3547/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>atazanavir</title>
		<link>http://i-base.info/guides/3545</link>
		<comments>http://i-base.info/guides/3545#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:59:15 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[PIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3545</guid>
		<description><![CDATA[
 at-az-ZAN-a-veer

Atazanavir (tradename Reyataz in Europe) is a protease inhibitor that is usually taken with a separate boosting dose of ritonavir.
Standard adult dose: 1 x 300 mg or 2 x 150 mg capsules, once-daily, usually plus 1 x 100 mg ritonavir. When ritonavir is not used the standard adult dose increases to 2 x 200 mg capsules, once-daily.
Needs to be [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3545/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>nevirapine</title>
		<link>http://i-base.info/guides/3543</link>
		<comments>http://i-base.info/guides/3543#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:56:29 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3543</guid>
		<description><![CDATA[ .       .       .
Nevirapine 200 mg            Nevirapine-PR (prolonged release) 400 mg
 neh-VYE-a-peen or neh-VIR-a-peen

Nevirapine (tradename Viramune in Europe) is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
There are two formulations: nevirapine (200 mg) and nevirapine prolonged release (400 mg).
In some countries nevirapine-PR is called nevirapine-XR (extended [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3543/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>tenofovir DF</title>
		<link>http://i-base.info/guides/3541</link>
		<comments>http://i-base.info/guides/3541#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:56:11 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3541</guid>
		<description><![CDATA[
 ten-OFF-oh-veer

Tenofovir DF (commonly called tenofovir, tradename Viread in Europe) is a nucleotide analogue.
In resource-limited countries this is a white tablet with the same design.
Standard adult dose: 1 x 300 mg tablet once-daily.
Tenofovir is recommended to be taken with food in Europe and with or without food in the US. Food increases tenofovir levels by [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3541/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combivir (AZT + 3TC)</title>
		<link>http://i-base.info/guides/3539</link>
		<comments>http://i-base.info/guides/3539#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:54:56 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3539</guid>
		<description><![CDATA[


Pronounced: KOM-biv-veer
Combivir is the European trade name for a fixed dose combination of AZT and 3TC.
Standard adult dose: one tablet, twice-daily.
Take with or without food.
Side effects: nausea, vomiting, fatigue, anaemia (low red blood cells), fat loss, muscle pain and weakness. Darkening of skin and nails in some people. Rarely, hair loss.
Other notes: do not use with d4T or FTC. [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3539/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FTC (emtricitabine)</title>
		<link>http://i-base.info/guides/3535</link>
		<comments>http://i-base.info/guides/3535#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:53:04 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3535</guid>
		<description><![CDATA[
EFF-tee-see (em-tri-SIT-uh-been)

FTC is also called emtricitabine (tradename Emtriva) is a nucleoside analogue.
Standard adult dose: 1 x 200mg capsule, once daily.
Can be taken with or without food.
Side effects: generally well tolerated, no common side effects.
FTC is included with tenofovir in the fixed dose combination Truvada.
FTC is included, with tenofovir and efavirenz, in the fixed dose combination Atripla.
Other notes. FTC [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3535/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AZT (zidovudine)</title>
		<link>http://i-base.info/guides/3531</link>
		<comments>http://i-base.info/guides/3531#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:52:31 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3531</guid>
		<description><![CDATA[

aie-zed-tee (zye-DOE-vue-deen)

AZT (also called zidovudine, tradename Retrovir in Europe) is a nucleoside analogue.
Standard adult dose: 1 x 250mg capsule, twice-daily.
Side effects: nausea, vomiting, fatigue, anaemia (low red blood cells), fat loss, muscle pain and weakness. Darkening of skin and nails in people of African origin.
Other notes: do not use with d4T. Methadone may increase the amount of [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3531/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ddI (didanosine)</title>
		<link>http://i-base.info/guides/3529</link>
		<comments>http://i-base.info/guides/3529#comments</comments>
		<pubDate>Tue, 12 Jan 2010 09:52:16 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3529</guid>
		<description><![CDATA[
dee-dee-EYE (dye-DAN-oh-seen)

ddI EC, also called didanosine (tradename Videx in Europe), is a nucleoside analogue. The EC stands for &#8216;enteric coating&#8217; as this slow-release capsule formulation replaced an earlier tablet.
Standard adult dose: 1 capsule, once-daily (200, 250 or 400 mg depending on weight).
Take on empty stomach (without food 2 hours either side of the dose)
Side effects: lactic acidosis, pancreatitis, peripheral neuropathy.
Other [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3529/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>abacavir</title>
		<link>http://i-base.info/guides/3521</link>
		<comments>http://i-base.info/guides/3521#comments</comments>
		<pubDate>Tue, 12 Jan 2010 08:57:21 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3521</guid>
		<description><![CDATA[

uh-BAK-a-veer or ay-BAK-a-veer

Abacavir (tradenames Ziagen in Europe and Epzicom in the US) is a nucleoside analogue.
Standard adult dose: 2 x 300 mg tablets, once-daily.
Can be taken with or without food.
Side effects: hypersensitvity reaction. A genetic test, called HLA B*5701, is now used in the UK that reduces this risk. A negative result does not guarantee that you [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3521/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>3TC (lamivudine)</title>
		<link>http://i-base.info/guides/3516</link>
		<comments>http://i-base.info/guides/3516#comments</comments>
		<pubDate>Tue, 12 Jan 2010 08:53:09 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3516</guid>
		<description><![CDATA[
 three-tee-see (la-MIV-vue-deen)

3TC, also called lamivudine, (tradename Epivir in Europe) is a nucleoside analogue.


Standard adult dose: 1 x 300mg or 2 x 150mg tablets, once-daily.
Can be taken with or without food.
Side effects: generally very easy to tolerate. Rare side effects include peripheral neuropathy and hair loss.
Other notes: 3TC is very similar to FTC. Do not take 3TC [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3516/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Kivexa (abacavir + 3TC)</title>
		<link>http://i-base.info/guides/3513</link>
		<comments>http://i-base.info/guides/3513#comments</comments>
		<pubDate>Tue, 12 Jan 2010 08:49:04 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=3513</guid>
		<description><![CDATA[
 kye-VEX-uh

Kivexa (tradename Kivexa in Europe and Epzicom in the US) a fixed dose combination of 3TC and abacavir.
Standard adult dose: 1 x tablet (containing 300 mg 3TC + 600 mg abacavir), once-daily.
Take with or without food.
Side effects: hypersensitvity reaction (from abacavir). A genetic test, called HLA B*5701, is now used in the UK that reduces this risk. [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/3513/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Guides sidebar</title>
		<link>http://i-base.info/guides/2528</link>
		<comments>http://i-base.info/guides/2528#comments</comments>
		<pubDate>Sun, 13 Sep 2009 10:48:10 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[Home]]></category>

		<guid isPermaLink="false">http://moomango.co.uk/guides/?p=2528</guid>
		<description><![CDATA[
Antiretroviral drugs
Order our guides for free

]]></description>
		<wfw:commentRss>http://i-base.info/guides/2528/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Truvada (tenofovir + FTC)</title>
		<link>http://i-base.info/guides/746</link>
		<comments>http://i-base.info/guides/746#comments</comments>
		<pubDate>Fri, 24 Apr 2009 13:14:59 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[Fixed dose combinations]]></category>
		<category><![CDATA[Nukes]]></category>

		<guid isPermaLink="false">http://localhost.localdomain/wpmu/guides/?p=746</guid>
		<description><![CDATA[
 tru-VAR-duh

Truvada is the tradename for a fixed dose combination of tenofovir and FTC.
In resource-limited countries this is a white tablet with the same design.
Standard adult dose: 1 tablet (containing 300 mg tenofovir + 200 mg FTC), once-daily.
Truvada is recommended to be taken with food in Europe and with or without food in the US. Food increases [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/746/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>efavirenz</title>
		<link>http://i-base.info/guides/734</link>
		<comments>http://i-base.info/guides/734#comments</comments>
		<pubDate>Fri, 24 Apr 2009 11:52:41 +0000</pubDate>
		<dc:creator>Web Team</dc:creator>
				<category><![CDATA[ARVs]]></category>
		<category><![CDATA[NNRTIs]]></category>

		<guid isPermaLink="false">http://localhost.localdomain/wpmu/guides/?p=734</guid>
		<description><![CDATA[
 ee-FAV-eer-enz

Efavirenz (tradenames Sustiva or Stocrin in some other European countries) is a non-nucleoside ﻿reverse transcriptase inhibitor (NNRTI).
Standard adult dose: 1 x  600 mg tablet, once-daily.
Side effects: sleep disturbance (including nightmares), mood changes (including anxiety and depression), rash, liver toxicity and lipid changes. Taking at night on an empty stomach can help reduce side effects.
Other notes: [...]]]></description>
		<wfw:commentRss>http://i-base.info/guides/734/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

